LONGEVITY & CELLULAR HEALTH
Longevity & Cellular Health research peptides: lifespan is not healthspan
A reference desk for two geroprotective peptides — epitalon and MOTS-c — read against the one distinction most longevity claims blur: how long an organism lives, versus how well it lives while it does.
MOTS-c
A sixteen-amino-acid peptide encoded inside the mitochondrial genome itself, induced by exercise and studied for what it does to muscle, glucose handling and physical capacity in ageing animals. Its endpoints are functional; no study here claims it lengthens life.
Read the research ›
Epitalon
A four-amino-acid pineal tetrapeptide, and the lead compound on this desk — the one with an actual survival-curve result behind it, and also the one whose evidence base rests most heavily on a single research lineage. Both facts are load-bearing.
Read the research ›The short version
yolopeptide is a reading desk. It is not a clinic and not a shop. It collects what the published research actually says about two peptides studied in ageing: epitalon, a four-amino-acid molecule modelled on an extract of the pineal gland (the small brain structure that releases melatonin at night), and MOTS-c, a sixteen-amino-acid molecule that the mitochondria — the compartments that supply a cell with energy — encode themselves.
Both are usually sold to the public with the same promise: more years. The research behind them mostly measures something else. Some studies count how long mice live. Some count how far old mice can still run. Some count how long a stretch of DNA is in a dish of cultured cells. Those are three different questions, and only the first is about lifespan.
This desk keeps them apart. Every figure on these pages carries a bracketed number pointing to the study it came from, and where the evidence is thin, the page says so rather than rounding up.
Two clocks: lifespan and healthspan
Lifespan is how long an organism lives. Healthspan is the portion of that life spent in good function — moving, metabolising, thinking. They are separate measurements, they can move in opposite directions, and a study almost never captures both. Most longevity marketing treats them as one word.
The clearest illustration in this small literature is an epitalon experiment in female SHR mice. Maximum lifespan rose 12.3% and survival of the last 10% of the cohort rose 13.3%, while mean lifespan was unchanged; chromosome aberrations in bone marrow fell 17.1%, leukaemia was inhibited 6.0-fold, and total tumour incidence did not change [11]. The tail of the survival curve moved. The typical mouse did not. A headline that reads "extends lifespan" is technically defensible and still describes a different animal than the reader has in mind.
The MOTS-c literature makes the opposite trade. Its signature ageing result measured what old animals could still do — treadmill running capacity, grip strength and gait in mice aged 22 to 23.5 months — and made no survival claim at all [4]. That is a healthspan-shaped finding with no lifespan attached.
Human data on both compounds are observational rather than interventional. For the pineal-peptide line it is a 6-to-8-year cohort of 266 elderly people given the parent extract, with no randomisation and no placebo arm [10]. For MOTS-c it is a marker study: circulating peptide levels tracked a mortality and cardiovascular endpoint in 94 chronic haemodialysis patients [2] — which measures the body's own peptide, not the effect of giving any.
What "research peptide" means on this desk
A peptide is a short chain of amino acids — the same chemistry as a protein, only small enough that the body treats it as a signal rather than a structure. Both compounds catalogued here are signalling molecules derived from something the body already makes, and neither is an approved medicine.
Epitalon has no FDA, EMA or MHRA approval and no registered indication; it is classified as a research chemical in the US, EU and UK. MOTS-c is likewise not FDA-approved for any use and is sold only for laboratory research, where product purity, identity and sterility are not regulated as they are for pharmaceuticals. MOTS-c is additionally treated as prohibited in elite sport by anti-doping authorities, and athletes face sanctions for its use. Epitalon is not specifically listed on the WADA Prohibited List as of this review, though peptide classifications are revised periodically and current status is worth checking independently.
Nothing on this site is a protocol. No human dose is given anywhere, including in the FAQ, where the question is asked directly.
How this desk reads a longevity claim
Three questions, applied in order, dispose of most of the noise.
Which species, and which model? A result in a cell-free assay, a cultured human fibroblast, a mouse oocyte and a live outbred mouse are four different kinds of evidence wearing the same headline.
Which endpoint? A survival curve, a functional test and a cell-culture surrogate answer different questions. Telomere length in a dish is not longevity; it is a measurement that correlates with replicative capacity under laboratory conditions.
Who else has reproduced it? This is where epitalon is weakest and it is stated plainly on its page: most of the foundational work comes from a single research lineage, and independent replication of the core telomere result was sparse until a 2025 study repeated it in human cell lines and found a second, less comfortable mechanism operating in cancer lines [7]. A finding that has not been reproduced outside the group that produced it is a hypothesis with a citation, not a settled fact.